GlassScriptVaprisol Dextrose In Plastic Container
Payments companies reported to CMS as associated with Vaprisol Dextrose In Plastic Container. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vaprisol Dextrose In Plastic Container, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vaprisol Dextrose In Plastic Container
These are the largest totals companies reported as associated with Vaprisol Dextrose In Plastic Container. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gordon Bernard | Nashville, TN | Critical Care Medicine (Internal Medicine) | $306,750.00 |
| Todd Rice | Nashville, TN | Critical Care Medicine (Internal Medicine) | $106,587.50 |
| Nikhil Bhayani | Bedford, TX | Infectious Disease | $7,000.00 |
| Bennett Deboisblanc | New Orleans, LA | Pulmonary Disease | $1,000.00 |
| Robert Roberts | Phoenix, AZ | Cardiovascular Disease | $1,000.00 |
Prescribed Vaprisol Dextrose In Plastic Container?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.